BCKDHB rs121908001: Understanding the p.Arg183Pro Variant
The rs121908001 variant in the BCKDHB gene is a pathogenic missense mutation known as p.Arg183Pro. It is associated with the development of autosomal recessive maple syrup urine disease type 1B, a metabolic disorder affecting the body's ability to process specific amino acids.
What each genotype means
Typical BCKDHB genotype
This genotype represents the common, non-pathogenic sequence for this location in the BCKDHB gene. Individuals with this result do not carry the specific R183P mutation associated with maple syrup urine disease type 1B.
This is the most common genotype found in the general population across all ancestries.
Carrier of MSUD mutation
This genotype indicates you are a carrier of the R183P mutation in the BCKDHB gene. Carriers are typically asymptomatic, but if both parents are carriers, there is a risk of passing the condition to offspring; consider genetic counseling if planning a family.
This genotype is found at a carrier frequency of approximately 1 in 113 in Ashkenazi Jewish populations and 1 in 176 in Mennonite populations.
Potential MSUD risk
This genotype indicates the presence of two copies of the R183P mutation, which is associated with maple syrup urine disease type 1B. This is a serious metabolic condition that requires clinical management and monitoring by a metabolic specialist.
This genotype is extremely rare in the general population and is typically only identified in individuals diagnosed with or being screened for maple syrup urine disease.
What is the rs121908001 Variant?
The variant rs121908001, often referred to by its protein-level change p.Arg183Pro, is a specific genetic alteration located within the BCKDHB gene. In genetic terms, this is a missense mutation, meaning a single nucleotide change results in the substitution of one amino acid for another in the final protein product. Specifically, an arginine is replaced by a proline at position 183. This change can disrupt the structural integrity or functional capacity of the protein encoded by the gene. Because this variant is classified as pathogenic, it is recognized by the scientific community as a cause of specific clinical conditions when inherited in a particular manner. It is important to note that genetic variants are simply variations in the DNA sequence, and their presence does not automatically imply a health condition, especially when only one copy of the variant is present.
The Role of the BCKDHB Gene
The BCKDHB gene provides the essential instructions for creating the E1 beta subunit of the branched-chain alpha-keto acid dehydrogenase (BCKD) complex. This protein complex acts as a critical metabolic machine within the body's cells. Its primary job is to break down three specific amino acids: leucine, isoleucine, and valine. These amino acids are the building blocks of proteins found in many common foods, such as meat, eggs, and milk. When the BCKD complex functions correctly, it ensures these amino acids are processed into energy. However, if the BCKDHB gene contains a mutation that prevents the complex from working, these amino acids and their toxic byproducts begin to accumulate in the blood and tissues. This buildup is the underlying cause of the metabolic challenges seen in conditions like maple syrup urine disease, as the body lacks the necessary tools to clear these substances effectively.
Research and Clinical Associations
Scientific research has established a clear link between mutations in the BCKDHB gene and maple syrup urine disease (MSUD). The rs121908001 variant is specifically identified as a pathogenic mutation that can lead to the classic form of this disorder. MSUD is an autosomal recessive condition, which means that an individual must inherit two copies of a pathogenic variant—one from each parent—to manifest the disease. Research indicates that individuals who carry only one copy of this variant are typically asymptomatic carriers. The evidence for this variant's pathogenicity is grounded in clinical observations of patients who present with the metabolic symptoms of MSUD and are found to have biallelic mutations in the BCKDHB gene. While the association is well-documented in clinical literature, the severity of the condition can vary based on the specific combination of mutations present in an individual's genetic profile.
Population Frequency and Distribution
The frequency of the rs121908001 variant varies significantly across different global populations. While it is a rare variant in the general population, it has been noted as a founder mutation in specific groups, such as the Ashkenazi Jewish population. Additionally, the broader condition of maple syrup urine disease is known to occur with higher frequency in the Old Order Mennonite population, where the incidence is estimated at approximately 1 in 380 newborns. This higher prevalence in certain communities is often due to the founder effect, where a specific genetic variant becomes more common within a group due to limited genetic diversity or historical population patterns. Understanding these population-specific frequencies is a key component of genetic research, as it helps clinicians and researchers better understand the distribution of rare metabolic disorders and the importance of genetic screening in specific ancestral groups.
What This Information Means for You
If you have received information regarding your status for the rs121908001 variant, it is important to interpret it within the context of your overall health and family history. Because this is a recessive variant, being a carrier (having one copy) generally does not cause symptoms of maple syrup urine disease. However, if you are planning a family, you may wish to discuss carrier screening with a genetic counselor. Genetic counselors are trained to help individuals understand the implications of their genetic results, the risks of passing on certain variants, and the options available for family planning. This information is for educational purposes only and should not be used to diagnose or treat any medical condition. Always consult with a qualified healthcare professional or a medical geneticist to discuss your specific genetic findings and what they mean for your personal health or family planning decisions.
How common is this variant?
The rs121908001 variant is rare in the general population but has been identified as a founder mutation in the Ashkenazi Jewish population with an allele frequency of approximately 0.005.
Frequently asked questions
What is maple syrup urine disease?
Maple syrup urine disease is a rare, inherited metabolic disorder where the body cannot properly break down certain amino acids. This leads to a buildup of toxic substances that can cause serious health issues if not managed through a specialized diet.
Does having one copy of this variant mean I have the disease?
No, because this condition is autosomal recessive, you typically need two copies of a pathogenic variant to manifest the disease. Carriers with only one copy generally do not show symptoms of the condition.
Should I be tested for this variant?
Genetic testing is a personal decision often discussed during family planning or if there is a family history of metabolic disorders. You should consult with a genetic counselor or your primary care physician to determine if testing is appropriate for your situation.
Can this variant be treated?
The variant itself is a permanent part of your DNA and cannot be changed. However, the metabolic condition associated with it is managed through strict dietary protein restriction and medical supervision to prevent the buildup of toxic amino acids.
Sources & further reading
Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908001?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BCKDHB
Pathogenic BCKDHB missense variant (p.Arg183Pro) causative of Maple Syrup Urine Disease (MSUD) type 1B, common in expanded carrier panels.
A missense variant (c.548A>G, p.Asn183Ser) in BCKDHB causing classic Maple Syrup Urine Disease (MSUD) type 1B in homozygotes and defining Ashkenazi Jewish carrier status.
Pathogenic variant (c.827T>G; p.Arg276Gly) associated with maple syrup urine disease type 1B.
This variant in the BCKDHB gene is linked to Maple Syrup Urine Disease and is documented in clinical variant databases.